R Squared LTD Biomarin Pharmaceutical Inc Transaction History
R Squared LTD
- $93.6 Billion
- Q1 2025
A detailed history of R Squared LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, R Squared LTD holds 5,550 shares of BMRN stock, worth $340,603. This represents 0.42% of its overall portfolio holdings.
Number of Shares
5,550
Previous 1,840
201.63%
Holding current value
$340,603
Previous $121 Million
224.39%
% of portfolio
0.42%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
654Shares Held
181MCall Options Held
1.67MPut Options Held
1.15M-
Black Rock Inc. New York, NY22.7MShares$1.4 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.17 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.09 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$918 Million0.65% of portfolio
-
Viking Global Investors LP10.5MShares$645 Million2.34% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...